Bovogen Biologicals Ultra Low IgG FBS

Sunday, 01 December, 2019 | Supplied by: Scientifix Pty Ltd

Bovogen Biologicals Ultra Low IgG FBS

Bovogen Biologicals’ foetal bovine serum (NZ origin) is manufactured in a fully validated sterile filtration facility, following strict GMP process, and is fully traceable. The FBS manufacturing process follows a strict quality controlled protocol.

All batches of FBS are triple 0.1 μm sterile filtered in a validated aseptic sterile filtration suite using a fully disposable closed loop filtration train. The closed-loop filtration system is fully disposable to ensure that all product contact parts are only used once, minimising any risk of contamination or human error.

The company’s latest product release is the Bovogen Ultra Low IgG FBS. Using a proprietary chromatographic process, IgG has been removed from the FBS with the ultimate goal of retaining the serum’s cellular viability and biological growth promoting activity. The IgG level in the UL IgG FBs is <0.5 ug/mL. Specific applications include monoclonal antibody research and production or where extremely low levels of IgG are required for cell culture and protein purification applications.

The product is manufactured by Bovogen Biologicals in 100 and 500 mL bottles, and distributed exclusively in Australia by Scientifix and Scientific Partners (WA).

Online: www.scientifix.com.au
Phone: 03 8540 5900
Related Products

Cayman Chemical Bio-Active Lipid I Screening Library (96-Well)

Cayman Chemical's Bio-Active Lipid I Screening Library consists of 13 plates and contains...

Echelon Biosciences ionisable lipids

Echelon Biosciences' ionisable lipids are the key components of lipid nanoparticles (LNPs)...

BioStatus CyTRAK Orange fluorescent dye

BioStatus's CyTRAK Orange is a novel fluorescent dye that preferentially stains the nucleus...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd